Title |
Mycobacterium Growth Inhibition Assay of Human Alveolar Macrophages as a Correlate of Immune Protection Following Mycobacterium bovis Bacille Calmette–Guérin Vaccination
|
---|---|
Published in |
Frontiers in immunology, July 2018
|
DOI | 10.3389/fimmu.2018.01708 |
Pubmed ID | |
Authors |
Juliane Radloff, Jan Heyckendorf, Lize van der Merwe, Patricia Sanchez Carballo, Norbert Reiling, Elvira Richter, Christoph Lange, Barbara Kalsdorf |
Abstract |
In order to eliminate tuberculosis (TB), an effective vaccine is urgently needed to prevent infection with Mycobacterium tuberculosis. A key obstacle for the development of novel TB vaccines is the lack of surrogate markers for immune protection against M. tuberculosis. We investigated growth rates of M. tuberculosis in the mycobacterial growth inhibition assay (MGIA) as a marker for mycobacterial growth control of human bronchoalveolar lavage (BALC) and peripheral blood mononuclear cells (PBMC) before and after vaccination with Mycobacterium bovis Bacille Calmette-Guérin (BCG) of healthy adult volunteers. Vaccination induced a positive response (p < 0.001) to purified protein derivate (PPD) in 58.8% of the individuals in an interferon-γ release assay-ELISpot. Intraindividual evaluation of the MGIA growth rates before and after M. bovis BCG-vaccination revealed no significant difference in time to culture positivity before and after vaccination in BALC (p = 0.604) and PBMC (p = 0.199). The magnitude of the PPD-response induced by M. bovis BCG-vaccination did not correlate with growth control in BALC and PBMC (correlation = 0.468, 95% CI: -0.016 to 0.775). In conclusion, M. bovis BCG-vaccination-induced mycobacterial-specific cytokine immune response does not result in functional immune control against M. tuberculosis in the MGIA. |
X Demographics
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Geographical breakdown
Country | Count | As % |
---|---|---|
United Kingdom | 1 | 14% |
Australia | 1 | 14% |
Canada | 1 | 14% |
United States | 1 | 14% |
Germany | 1 | 14% |
Unknown | 2 | 29% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Scientists | 4 | 57% |
Members of the public | 3 | 43% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 39 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Ph. D. Student | 5 | 13% |
Student > Bachelor | 5 | 13% |
Student > Master | 5 | 13% |
Researcher | 4 | 10% |
Student > Doctoral Student | 2 | 5% |
Other | 4 | 10% |
Unknown | 14 | 36% |
Readers by discipline | Count | As % |
---|---|---|
Biochemistry, Genetics and Molecular Biology | 6 | 15% |
Immunology and Microbiology | 6 | 15% |
Medicine and Dentistry | 6 | 15% |
Agricultural and Biological Sciences | 2 | 5% |
Computer Science | 1 | 3% |
Other | 3 | 8% |
Unknown | 15 | 38% |